{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:38:36Z","timestamp":1794965916285,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL164949"],"award-info":[{"award-number":["HL164949"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL151328"],"award-info":[{"award-number":["P01HL151328"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL160470"],"award-info":[{"award-number":["HL160470"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35HL150754"],"award-info":[{"award-number":["R35HL150754"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68193-3","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:05:02Z","timestamp":1767423902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice"],"prefix":"10.1038","volume":"17","author":[{"given":"Ainara G.","family":"Cabodevilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concepcion","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debapriya","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-7925","authenticated-orcid":false,"given":"Munichandra Babu","family":"Tirumalasetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-1238","authenticated-orcid":false,"given":"Qing Robert","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Nasias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-772X","authenticated-orcid":false,"given":"Jenny E.","family":"Kanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-7859","authenticated-orcid":false,"given":"Tse Wing Winnie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Gjini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-143X","authenticated-orcid":false,"given":"Edward","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-6587","authenticated-orcid":false,"given":"Warren L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-6523","authenticated-orcid":false,"given":"Karin","family":"Bornfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-2201","authenticated-orcid":false,"given":"Ira J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"68193_CR1","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1172\/JCI107331","volume":"52","author":"JL Goldstein","year":"1973","unstructured":"Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L. & Motulsky, A. G. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 52, 1533\u20131543 (1973).","journal-title":"J. Clin. Invest."},{"key":"68193_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","volume":"60","author":"DB Zilversmit","year":"1979","unstructured":"Zilversmit, D. B. Atherogenesis: a postprandial phenomenon. Circulation 60, 473\u2013485 (1979).","journal-title":"Circulation"},{"key":"68193_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dbi19-0007","volume":"69","author":"A Chait","year":"2020","unstructured":"Chait, A. et al. Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease. Diabetes 69, 508\u2013516 (2020).","journal-title":"Diabetes"},{"key":"68193_CR4","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg, H. N. et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European Atherosclerosis Society. Eur. Heart J. 42, 4791\u20134806 (2021).","journal-title":"Eur. Heart J."},{"key":"68193_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00041433-200012000-00008","volume":"11","author":"RJ Havel","year":"2000","unstructured":"Havel, R. J. Remnant lipoproteins as therapeutic targets. Curr. Opin. Lipido. 11, 615\u2013620 (2000).","journal-title":"Curr. Opin. Lipido."},{"key":"68193_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11892-024-01555-1","volume":"24","author":"D Elias-Lopez","year":"2024","unstructured":"Elias-Lopez, D., Wadstrom, B. N., Vedel-Krogh, S., Kobylecki, C. J. & Nordestgaard, B. G. Impact of remnant cholesterol on cardiovascular risk in diabetes. Curr. Diab. Rep. 24, 290\u2013300 (2024).","journal-title":"Curr. Diab. Rep."},{"key":"68193_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1161\/01.ATV.8.4.421","volume":"8","author":"BG Nordestgaard","year":"1988","unstructured":"Nordestgaard, B. G., Stender, S. & Kjeldsen, K. Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall. Arteriosclerosis 8, 421\u2013428 (1988).","journal-title":"Arteriosclerosis"},{"key":"68193_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fendo.2020.00474","volume":"11","author":"J Boren","year":"2020","unstructured":"Boren, J., Packard, C. J. & Taskinen, M. R. The roles of ApoC-III on the metabolism of triglyceride-rich lipoproteins in humans. Front. Endocrinol. 11, 474 (2020).","journal-title":"Front. Endocrinol."},{"key":"68193_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa2409368","volume":"392","author":"GF Watts","year":"2025","unstructured":"Watts, G. F. et al. Plozasiran for managing persistent chylomicronemia and pancreatitis risk. N. Engl. J. Med. 392, 127\u2013137 (2025).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR10","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jacc.2021.01.053","volume":"77","author":"T Szili-Torok","year":"2021","unstructured":"Szili-Torok, T. & Tietge, U. J. F. Remnant cholesterol is just another word for triglycerides when calculating LDL-C using the Friedewald formula. J. Am. Coll. Cardiol. 77, 1841 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68193_CR11","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1083\/jcb.96.6.1677","volume":"96","author":"E Vasile","year":"1983","unstructured":"Vasile, E., Simionescu, M. & Simionescu, N. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J. Cell Biol. 96, 1677\u20131689 (1983).","journal-title":"J. Cell Biol."},{"key":"68193_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/cvr\/cvv218","volume":"108","author":"SM Armstrong","year":"2015","unstructured":"Armstrong, S. M. et al. A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis. Cardiovasc. Res. 108, 268\u2013277 (2015).","journal-title":"Cardiovasc. Res."},{"key":"68193_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1140-4","volume":"569","author":"L Huang","year":"2019","unstructured":"Huang, L. et al. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature 569, 565\u2013569 (2019).","journal-title":"Nature"},{"key":"68193_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s44161-023-00266-2","volume":"2","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. Genetic or therapeutic neutralization of ALK1 reduces LDL transcytosis and atherosclerosis in mice. Nat. Cardiovasc. Res. 2, 438\u2013448 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"68193_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"271","author":"S Acton","year":"1996","unstructured":"Acton, S. et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518\u2013520 (1996).","journal-title":"Science"},{"key":"68193_CR16","doi-asserted-by":"crossref","unstructured":"Cabodevilla, A. G. et al. Eruptive xanthoma model reveals endothelial cells internalize and metabolize chylomicrons, leading to extravascular triglyceride accumulation. J. Clin. Invest. 131, e145800 (2021).","DOI":"10.1172\/JCI145800"},{"key":"68193_CR17","doi-asserted-by":"publisher","first-page":"18401","DOI":"10.1074\/jbc.M401170200","volume":"279","author":"R Out","year":"2004","unstructured":"Out, R. et al. Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J. Biol. Chem. 279, 18401\u201318406 (2004).","journal-title":"J. Biol. Chem."},{"key":"68193_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCRESAHA.116.310498","volume":"120","author":"A Kuo","year":"2017","unstructured":"Kuo, A., Lee, M. Y. & Sessa, W. C. Lipid droplet biogenesis and function in the endothelium. Circ. Res. 120, 1289\u20131297 (2017).","journal-title":"Circ. Res."},{"key":"68193_CR19","doi-asserted-by":"crossref","unstructured":"Kim, B. et al. Endothelial lipid droplets suppress eNOS to link high fat consumption to blood pressure elevation. J. Clin. Invest. 133, e173160 (2023).","DOI":"10.1172\/JCI173160"},{"key":"68193_CR20","doi-asserted-by":"crossref","unstructured":"Boutagy, N. E. et al. Dynamic metabolism of endothelial triglycerides protects against atherosclerosis in mice. J. Clin. Invest. 134, e170453 (2024).","DOI":"10.1172\/JCI170453"},{"key":"68193_CR21","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","volume":"64","author":"RS Rosenson","year":"2014","unstructured":"Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S. & Gaudet, D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J. Am. Coll. Cardiol. 64, 2525\u20132540 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68193_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jama.298.3.336","volume":"298","author":"PE McBride","year":"2007","unstructured":"McBride, P. E. Triglycerides and risk for coronary heart disease. JAMA 298, 336\u2013338 (2007).","journal-title":"JAMA"},{"key":"68193_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJM199609193351203","volume":"335","author":"P Benlian","year":"1996","unstructured":"Benlian, P. et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335, 848\u2013854 (1996).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jacl.2022.07.013","volume":"16","author":"GB Vigna","year":"2022","unstructured":"Vigna, G. B., Citroni, N., Tarugi, P. & Fellin, R. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations. J. Clin. Lipido. 16, 591\u2013595 (2022).","journal-title":"J. Clin. Lipido."},{"key":"68193_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MOL.0000000000000682","volume":"31","author":"CAA Salinas","year":"2020","unstructured":"Salinas, C. A. A. & Chapman, M. J. Remnant lipoproteins: are they equal to or more atherogenic than LDL? Curr. Opin. Lipido. 31, 132\u2013139 (2020).","journal-title":"Curr. Opin. Lipido."},{"key":"68193_CR26","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1172\/JCI118319","volume":"96","author":"PH Weinstock","year":"1995","unstructured":"Weinstock, P. H. et al. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96, 2555\u20132568 (1995).","journal-title":"J. Clin. Invest."},{"key":"68193_CR27","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1172\/JCI86610","volume":"126","author":"PL Gordts","year":"2016","unstructured":"Gordts, P. L. et al. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors. J. Clin. Invest. 126, 2855\u20132866 (2016).","journal-title":"J. Clin. Invest."},{"key":"68193_CR28","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","volume":"371","author":"D Gaudet","year":"2014","unstructured":"Gaudet, D. et al. Targeting APOC3 in the familial chylomicronemia syndrome. N. Engl. J. Med. 371, 2200\u20132206 (2014).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR29","doi-asserted-by":"crossref","unstructured":"Thajer, A., Skacel, G., de Gier, C. & Greber-Platzer, S. The effect of a fat-restricted diet in four patients with familial chylomicronemia syndrome: a long-term follow-up study. Children 8, 1078 (2021).","DOI":"10.3390\/children8111078"},{"key":"68193_CR30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jacl.2023.09.012","volume":"17","author":"Y Xia","year":"2023","unstructured":"Xia, Y. et al. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency. J. Clin. Lipido. 17, 808\u2013817 (2023).","journal-title":"J. Clin. Lipido."},{"key":"68193_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI114732","volume":"86","author":"IJ Goldberg","year":"1990","unstructured":"Goldberg, I. J., Blaner, W. S., Vanni, T. M., Moukides, M. & Ramakrishnan, R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J. Clin. Invest. 86, 463\u2013473 (1990).","journal-title":"J. Clin. Invest."},{"key":"68193_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/CIRCRESAHA.117.311361","volume":"122","author":"D Basu","year":"2018","unstructured":"Basu, D. et al. Novel reversible model of atherosclerosis and regression using oligonucleotide regulation of the LDL receptor. Circ. Res. 122, 560\u2013567 (2018).","journal-title":"Circ. Res."},{"key":"68193_CR33","doi-asserted-by":"publisher","first-page":"26293","DOI":"10.1074\/jbc.M002423200","volume":"275","author":"VR Babaev","year":"2000","unstructured":"Babaev, V. R., Patel, M. B., Semenkovich, C. F., Fazio, S. & Linton, M. F. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J. Biol. Chem. 275, 26293\u201326299 (2000).","journal-title":"J. Biol. Chem."},{"key":"68193_CR34","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1194\/jlr.M035568","volume":"54","author":"M Takahashi","year":"2013","unstructured":"Takahashi, M. et al. Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity. J. Lipid Res. 54, 1124\u20131134 (2013).","journal-title":"J. Lipid Res."},{"key":"68193_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/ATVBAHA.117.310607","volume":"38","author":"CL Chang","year":"2018","unstructured":"Chang, C. L. et al. Lipoprotein lipase deficiency impairs bone marrow myelopoiesis and reduces circulating monocyte levels. Arterioscler. Thromb. Vasc. Biol. 38, 509\u2013519 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68193_CR36","doi-asserted-by":"publisher","unstructured":"Tilp, A. et al. Extracellular vesicles from chylomicron-treated endothelial cells drive macrophage inflammation. bioRxiv https:\/\/doi.org\/10.1101\/2025.02.28.640926 (2025).","DOI":"10.1101\/2025.02.28.640926"},{"key":"68193_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1172\/JCI8623","volume":"105","author":"J Twisk","year":"2000","unstructured":"Twisk, J. et al. The role of the LDL receptor in apolipoprotein B secretion. J. Clin. Invest. 105, 521\u2013532 (2000).","journal-title":"J. Clin. Invest."},{"key":"68193_CR38","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.1016\/S0021-9258(17)44822-8","volume":"265","author":"KJ Williams","year":"1990","unstructured":"Williams, K. J., Brocia, R. W. & Fisher, E. A. The unstirred water layer as a site of control of apolipoprotein B secretion. J. Biol. Chem. 265, 16741\u201316744 (1990).","journal-title":"J. Biol. Chem."},{"key":"68193_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","volume":"118","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard, B. G. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ. Res. 118, 547\u2013563 (2016).","journal-title":"Circ. Res."},{"key":"68193_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0021-9150(80)90102-1","volume":"37","author":"M Kekki","year":"1980","unstructured":"Kekki, M. Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics. Atherosclerosis 37, 143\u2013150 (1980).","journal-title":"Atherosclerosis"},{"key":"68193_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0021-9150(82)90202-7","volume":"41","author":"MR Taskinen","year":"1982","unstructured":"Taskinen, M. R. et al. In vitro catabolism of human plasma very low density lipoproteins: effects of VLDL concentration on the interconversion of high density lipoprotein subfractions. Atherosclerosis 41, 381\u2013394 (1982).","journal-title":"Atherosclerosis"},{"key":"68193_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fcvm.2018.00130","volume":"5","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Sessa, W. C. & Fernandez-Hernando, C. Endothelial transcytosis of lipoproteins in atherosclerosis. Front. Cardiovasc. Med. 5, 130 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"68193_CR43","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajhg.2023.03.013","volume":"110","author":"T Ord","year":"2023","unstructured":"Ord, T. et al. Dissecting the polygenic basis of atherosclerosis via disease-associated cell state signatures. Am. J. Hum. Genet. 110, 722\u2013740 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"68193_CR44","first-page":"E53","volume":"20","author":"M Van Eck","year":"2000","unstructured":"Van Eck, M., Zimmermann, R., Groot, P. H., Zechner, R. & Van Berkel, T. J. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20, E53\u2013E62 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68193_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00365518709168149","volume":"186","author":"BG Nordestgaard","year":"1987","unstructured":"Nordestgaard, B. G., Stender, S. & Kjeldsen, K. Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis. Scand. J. Clin. Lab Invest. Suppl. 186, 7\u201312 (1987).","journal-title":"Scand. J. Clin. Lab Invest. Suppl."},{"key":"68193_CR46","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1172\/JCI2912","volume":"102","author":"M Merkel","year":"1998","unstructured":"Merkel, M. et al. Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. J. Clin. Invest. 102, 893\u2013901 (1998).","journal-title":"J. Clin. Invest."},{"key":"68193_CR47","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCRESAHA.107.156554","volume":"102","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ. Res. 102, 250\u2013256 (2008).","journal-title":"Circ. Res."},{"key":"68193_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.109.196329","volume":"30","author":"MM Weinstein","year":"2010","unstructured":"Weinstein, M. M. et al. Chylomicronemia elicits atherosclerosis in mice\u2013brief report. Arterioscler. Thromb. Vasc. Biol. 30, 20\u201323 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68193_CR49","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0022-2275(20)32538-4","volume":"39","author":"CF Semenkovich","year":"1998","unstructured":"Semenkovich, C. F., Coleman, T. & Daugherty, A. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J. Lipid Res. 39, 1141\u20131151 (1998).","journal-title":"J. Lipid Res."},{"key":"68193_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cca.2007.08.011","volume":"386","author":"T Ebara","year":"2007","unstructured":"Ebara, T. et al. A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis. Clin. Chim. Acta 386, 100\u2013104 (2007).","journal-title":"Clin. Chim. Acta"},{"key":"68193_CR51","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1210\/jc.2005-1098","volume":"90","author":"MA Kawashiri","year":"2005","unstructured":"Kawashiri, M. A. et al. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis. J. Clin. Endocrinol. Metab. 90, 6541\u20136544 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68193_CR52","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jacc.2018.06.042","volume":"72","author":"NP Shah","year":"2018","unstructured":"Shah, N. P., Cho, L. & Ahmed, H. M. Familial chylomicronemia syndrome: clinical characteristics and long-term cardiovascular outcomes. J. Am. Coll. Cardiol. 72, 1177\u20131179 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68193_CR53","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1161\/01.ATV.19.6.1535","volume":"19","author":"HH Wittrup","year":"1999","unstructured":"Wittrup, H. H. et al. Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen City Heart Study. Arterioscler. Thromb. Vasc. Biol. 19, 1535\u20131540 (1999).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68193_CR54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MED.0000000000000714","volume":"29","author":"KG Parhofer","year":"2022","unstructured":"Parhofer, K. G. New targets for treating hypertriglyceridemia. Curr. Opin. Endocrinol. Diab. Obes. 29, 106\u2013111 (2022).","journal-title":"Curr. Opin. Endocrinol. Diab. Obes."},{"key":"68193_CR55","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jama.2017.0972","volume":"317","author":"AV Khera","year":"2017","unstructured":"Khera, A. V. et al. Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease. JAMA 317, 937\u2013946 (2017).","journal-title":"JAMA"},{"key":"68193_CR56","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/aje\/kwn235","volume":"168","author":"GS Sagoo","year":"2008","unstructured":"Sagoo, G. S. et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am. J. Epidemiol. 168, 1233\u20131246 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"68193_CR57","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","volume":"374","author":"FE Dewey","year":"2016","unstructured":"Dewey, F. E. et al. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N. Engl. J. Med. 374, 1123\u20131133 (2016).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR58","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","volume":"374","author":"G Myocardial Infarction","year":"2016","unstructured":"Myocardial Infarction, G. et al. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134\u20131144 (2016).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1308027","volume":"371","author":"AB Jorgensen","year":"2014","unstructured":"Jorgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G. & Tybjaerg-Hansen, A. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N. Engl. J. Med. 371, 32\u201341 (2014).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR60","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1126\/science.1161524","volume":"322","author":"TI Pollin","year":"2008","unstructured":"Pollin, T. I. et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702\u20131705 (2008).","journal-title":"Science"},{"key":"68193_CR61","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","volume":"366","author":"A Keech","year":"2005","unstructured":"Keech, A. et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366, 1849\u20131861 (2005).","journal-title":"Lancet"},{"key":"68193_CR62","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","volume":"362","author":"AS Group","year":"2010","unstructured":"Group, A. S. et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1563\u20131574 (2010).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR63","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","volume":"387","author":"A Das Pradhan","year":"2022","unstructured":"Das Pradhan, A. et al. Triglyceride lowering with pemafibrate to reduce cardiovascular risk. N. Engl. J. Med. 387, 1923\u20131934 (2022).","journal-title":"N. Engl. J. Med."},{"key":"68193_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard, B. G., Benn, M., Schnohr, P. & Tybjaerg-Hansen, A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299\u2013308 (2007).","journal-title":"JAMA"},{"key":"68193_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-60327-369-5_5","volume":"1027","author":"JE Feig","year":"2013","unstructured":"Feig, J. E. & Fisher, E. A. Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions. Methods Mol. Biol. 1027, 123\u2013135 (2013).","journal-title":"Methods Mol. Biol."},{"key":"68193_CR66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1161\/ATVBAHA.107.157685","volume":"28","author":"S Subramanian","year":"2008","unstructured":"Subramanian, S. et al. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 685\u2013691 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68193_CR67","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCRESAHA.120.317458","volume":"128","author":"T Josefs","year":"2021","unstructured":"Josefs, T. et al. Atherosclerosis regression and cholesterol efflux in hypertriglyceridemic mice. Circ. Res. 128, 690\u2013705 (2021).","journal-title":"Circ. Res."},{"key":"68193_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"68193_CR69","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"68193_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"68193_CR71","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. Using clusterProfiler to characterize multiomics data. Nat. Protoc. 19, 3292\u20133320 (2024).","journal-title":"Nat. Protoc."},{"key":"68193_CR72","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1161\/ATVBAHA.118.310792","volume":"38","author":"S Ghaffari","year":"2018","unstructured":"Ghaffari, S., Naderi Nabi, F., Sugiyama, M. G. & Lee, W. L. Estrogen inhibits LDL (low-density lipoprotein) transcytosis by human coronary artery endothelial cells via GPER (G-protein-coupled estrogen receptor) and SR-BI (Scavenger receptor class B type 1). Arterioscler. Thromb. Vasc. Biol. 38, 2283\u20132294 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68193-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:03:34Z","timestamp":1770642214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68193-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68193"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68193-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5451391\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1458"}}